Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression

被引:2
|
作者
Del Sant, L. C. [1 ]
Magalhaes, E. [1 ]
Lucchese, A. C. [1 ]
Palhares Alves, H. N. [1 ]
Sarin, L. M. [1 ]
Del Porto, J. A. [1 ]
Tavares de lacerda, A. L. [1 ]
机构
[1] Univ Fed Sao Paulo, Psychiat, Sao Paulo, Brazil
关键词
D O I
10.1016/j.eurpsy.2017.01.704
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
EV0374
引用
收藏
页码:S525 / S526
页数:2
相关论文
共 50 条
  • [21] REM density predicts rapid antidepressant response to ketamine in individuals with treatment-resistant depression
    Kheirkhah, Mina
    Duncan Jr, Wallace C.
    Yuan, Qiaoping
    Wang, Philip R.
    Jamalabadi, Hamidreza
    Leistritz, Lutz
    Walter, Martin
    Goldman, David
    Zarate, Carlos A.
    Hejazi, Nadia S.
    NEUROPSYCHOPHARMACOLOGY, 2025,
  • [22] The cortisol awakening response in treatment-resistant depression is not a biomarker of the clinical response to ketamine
    Naughton, M.
    Allen, A. P.
    Clarke, G.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    Cryan, J. F.
    Dinan, T. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S401 - S401
  • [23] Clinical Predictors of Placebo Response in Treatment-Resistant Major Depression
    Yazdian, Aaron L.
    Park, Lawrence
    Luckenbaugh, David A.
    Niciu, Mark J.
    Lener, Marc
    Nugent, Allison C.
    Ballard, Elizabeth D.
    Brutsche, Nancy E.
    Zarate, Carlos A.
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 260S - 260S
  • [24] KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE
    Bobo, William V.
    Vande Voort, Jennifer L.
    Croarkin, Paul E.
    Leung, Jonathan G.
    Tye, Susannah J.
    Frye, Mark A.
    DEPRESSION AND ANXIETY, 2016, 33 (08) : 698 - 710
  • [25] Association between peripheral biomarkers and clinical response to IV ketamine for unipolar treatment-resistant depression: An open label study
    Kang, Melody J. Y.
    Vazquez, Gustavo H.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 318 : 331 - 337
  • [26] Antidepressant Effects of Single and Repeated Ketamine Infusions in Treatment-Resistant Depression
    Phillips, Jennifer
    Norris, Sandhaya
    Talbot, Jeanne
    Ortiz, Abigail
    Birmingham, Meagan
    Blier, Pierre
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S410 - S410
  • [27] Ketamine for Treatment-Resistant Unipolar DepressionCurrent Evidence
    Sanjay J. Mathew
    Asim Shah
    Kyle Lapidus
    Crystal Clark
    Noor Jarun
    Britta Ostermeyer
    James W. Murrough
    CNS Drugs, 2012, 26 : 189 - 204
  • [28] Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study
    Nugent, Allison C.
    Wills, Kathleen E.
    Gilbert, Jessica R.
    Zarate, Carlos A., Jr.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2019, 283 : 64 - 66
  • [29] Magnetoencephalography biomarkers of suicide attempt history and antidepressant response to ketamine in treatment-resistant major depression
    Gilbert, Jessica R.
    Gerner, Jessica L.
    Burton, Courtney R.
    Nugent, Allison C.
    Zarate, Carlos A., Jr.
    Ballard, Elizabeth D.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 312 : 188 - 197
  • [30] Repeated Administrations of Ketamine in Treatment-Resistant Major Depression: Rapid Antidepressant Effects and Durability of Response
    Murrough, James W.
    Perez, Andrew M.
    Pillemer, Sarah
    Stem, Jessica
    Lapidus, Kyle
    Soleimani, Laili
    Alves, Diogo K.
    Charney, Dennis S.
    Iosifescu, Dan V.
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 60S - 60S